Quince Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QNCX and other ETFs, options, and stocks.About QNCX
Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes EryDex, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells.
CEODirk Thye
CEODirk Thye
Employees36
Employees36
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2012
Founded2012
Employees36
Employees36
QNCX Key Statistics
Market cap222.73M
Market cap222.73M
Price-Earnings ratio-3.29
Price-Earnings ratio-3.29
Dividend yield—
Dividend yield—
Average volume1.57M
Average volume1.57M
High today$4.30
High today$4.30
Low today$3.65
Low today$3.65
Open price$3.67
Open price$3.67
Volume1.80M
Volume1.80M
52 Week high$4.30
52 Week high$4.30
52 Week low$0.7203
52 Week low$0.7203
Stock Snapshot
The current Quince Therapeutics(QNCX) stock price is $3.93, with a market capitalization of 222.73M. The stock trades at a price-to-earnings (P/E) ratio of -3.29.
During the trading session on 2025-12-07, Quince Therapeutics(QNCX) shares reached a daily high of $4.30 and a low of $3.65. At a current price of $3.93, the stock is +7.7% higher than the low and still -8.6% under the high.
Trading volume for Quince Therapeutics(QNCX) stock has reached 1.8M, versus its average volume of 1.57M.
Over the past 52 weeks, Quince Therapeutics(QNCX) stock has traded between a high of $4.30 and a low of $0.72.
Over the past 52 weeks, Quince Therapeutics(QNCX) stock has traded between a high of $4.30 and a low of $0.72.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own QNCX. This list is generated using Robinhood data, and it’s not a recommendation.